Johnson & Johnson JNJ
NYSE JNJ
$267.05 -0.03 (-0.01%)
As of: Sep 10, 2026 · 2:44 PM EDT

Johnson & Johnson (JNJ) Assets Average (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Assets Average came in at $201.0 billion in Q2 2026, up 3.85% year-over-year from $193.5 billion in Q2 2025, and little changed quarter-over-quarter from $200.1 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Assets Average (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Assets Average across 18 years of filings, most recently posting $201.0 billion for Q2 2026.

  • In Q2 2026, Assets Average rose 3.85% year-over-year to $201.0 billion; the TTM figure through Jun 2026 stood at $201.0 billion (up 3.85% YoY), while the FY2025 annual figure was $189.7 billion, up 9.1% from the prior year.
  • Assets Average came in at $201.0 billion for Q2 2026 at Johnson & Johnson, roughly flat from $200.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $201.0 billion in Q2 2026 to a low of $166.8 billion in Q4 2023.
  • Average Assets Average over 5 years is $184.4 billion, with a median of $180.6 billion recorded in 2022.
  • Year-over-year, Assets Average fell 11.43% in 2024 and advanced 10.09% in 2025.
  • Over 5 years, Assets Average stood at $176.4 billion in 2022, then fell by 5.45% to $166.8 billion in 2023, then grew by 7.43% to $179.2 billion in 2024, then rose by 9.39% to $196.0 billion in 2025, then rose by 2.53% to $201.0 billion in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $201.0 billion in Q2 2026, $200.1 billion in Q1 2026, and $196.0 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 643.20 Bn 622.44 Bn 17.26 Bn 200.98 Bn
2 AbbVie 448.14 Bn 441.57 Bn 12.70 Bn 135.79 Bn
3 Merck 358.13 Bn 350.98 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 267.81 Bn 260.12 Bn 11.24 Bn 120.28 Bn
5 Pfizer 156.55 Bn 144.85 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.17 Bn 44.78 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 42.92 Bn 42.92 Bn - 3.29 Bn
8 Incyte 24.72 Bn 20.19 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn 6.97 Bn
10 Neurocrine Biosciences 15.83 Bn 15.44 Bn 935.80 Mn 5.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 200.98 Bn
Mar 29, 2026 200.05 Bn
Dec 28, 2025 196.01 Bn
Sep 28, 2025 193.10 Bn
Jun 29, 2025 193.53 Bn
Mar 30, 2025 186.89 Bn
Dec 29, 2024 179.20 Bn
Sep 29, 2024 179.69 Bn
Jun 30, 2024 176.53 Bn
Mar 31, 2024 169.76 Bn
Dec 31, 2023 166.81 Bn
Oct 1, 2023 178.87 Bn
Jul 2, 2023 193.83 Bn
Apr 2, 2023 191.67 Bn
Jan 1, 2023 181.25 Bn
Oct 2, 2022 176.42 Bn
Jul 3, 2022 178.04 Bn
Apr 3, 2022 180.19 Bn
Jan 2, 2022 180.62 Bn
Oct 3, 2021 177.83 Bn